Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À§Àå°ü Áõ¼¼ À§ÁÖ·Î ¹ßÇöÇÏ´Â ¿µÀ¯¾Æ±â ¿ìÀ¯ ¾Ë·¹¸£±â ÁúȯÀÇ 3°¡Áö ÀÓ»ó À¯Çü¿¡ °üÇÑ °íÂû The Three Types of Clinical Manifestation of Cow¡¯s Milk Allergy with Predominantly Intestinal Symptoms

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2000³â 3±Ç 1È£ p.30 ~ 40
ÀÌÁ¤Áø, ±è¿ëÁø, Á¤Çý¸®, ȲÁøº¹, ÇÑâȣ, ÃÖÀºÁø, ±Ç¿µ´ë, ±èÇöÈñ, ÀÌÀºÁÖ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤Áø ( Lee Jeong-Jin ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

±è¿ëÁø ( Kim Yong-Jin ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ Çغκ´¸®Çб³½Ç
Á¤Çý¸® ( Chung Hai-Lee ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ȲÁøº¹ ( Hwang Jin-Bok ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÇÑâȣ ( Han Chang-Ho ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÃÖÀºÁø ( Choi Eun-Jin ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±Ç¿µ´ë ( Kwon Young-Dae ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±èÇöÈñ ( Kim Hyun-Hee ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÀÌÀºÁÖ ( Lee Eun-Joo ) 
´ë±¸È¿¼º°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñÀû : À§Àå°ü Áõ¼¼ À§ÁÖ·Î ¹ßÇöÇÏ´Â ¿ìÀ¯ ¾Ë·¹¸£±â(cow¡¯s milk allergy with
predominantly gastrointestinal symptoms, CMA-GI)´Â À¯¹ß½ÃÇè ÈÄ À¯ÇعÝÀÀÀÇ ¹ßÇö½Ã°£ÀÌ
Áï°¢ÀûÀÌÁö ¾Ê¾Æ º´·ÂûÃ븦 ÅëÇÏ¿© ¿ìÀ¯¿Í ¹ßÇö Áõ»óÀÇ °ü·Ã¼ºÀ» ÀǽÉÇϱⰡ ½±Áö ¾Ê´Ù.
¶ÇÇÑ, °¡º­¿î ±¸Åä, ¼³»ç Áõ»óºÎÅÍ ±«»ç¼º Àå¿°ÀÇ ¹ßº´Ã³·³ ³ôÀº »ç¸Á·üÀ» º¸ÀÌ´Â °æ¿ì±îÁö
ÀÓ»óÀû ½ºÆÑÆ®·³ÀÌ ´Ù¾çÇϸç, °¨¿°¼º Áúȯ µî Ÿ Áúȯ°úÀÇ Ã¶ÀúÇÑ °¨º°Áø´ÜÀÌ ¿ä±¸µÇ³ª ¾î
·Á¿î °æ¿ì°¡ ¸¹´Ù. ÀúÀÚµéÀº CMA-GI¸¦ 3°¡Áö ÀÓ»óÀ¯ÇüÀ¸·Î ºÐ·ùÇÏ¿© Áø´ÜÀû È¿¿ë¼ºÀ» ³ô
ÀÌ°í, È¿À²ÀûÀÎ Ä¡·á°èȹ ¼ö¸³¿¡ µµ¿òÀ» ÁÖ°íÀÚ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý : 1995³â 3¿ùºÎÅÍ 1997³â 6¿ù±îÁö ´ë±¸È¿¼º°¡Å縯´ëÇк´¿ø ¼Ò¾Æ°ú¿¡ ±Þ, ¸¸¼º
¼³»ç µî À§Àå°ü Áõ¼¼¸¦ ÁÖ¼Ò·Î ³»¿øÇÏ¿© ¿ìÀ¯Á¦°Å ¹× À¯¹ß½ÃÇèÀÇ ¹ÝÀÀÀ» ±Ù°Å·Î CMA-GI
·Î Áø´ÜµÈ 30¸í(³² 22¸í, ¿© 8¸í)ÀÇ ¿µÀ¯¾Æ¸¦ ´ë»óÀ¸·Î ¿ìÀ¯ À¯¹ß½ÃÇè¿¡ µû¸¥ À¯ÇعÝÀÀÀÇ ¹ß
Çö½Ã±â ¹× ¾ç»ó¿¡ µû¶ó 3°¡Áö ÀÓ»ó À¯ÇüÀ¸·Î ºÐ·ùÇÏ°í, ÀÔ¿ø´ç½Ã ÀÓ»ó¼Ò°ß, À¯ÇعÝÀÀÀÇ ¾ç
»ó, ¸é¿ªÇÐÀû °Ë»ç¼Ò°ß, ¼ÒÀå »ý°ËÁ¶Á÷ÀÇ ÇüÅÂÇÐÀû ºÐ¼® µîÀ» ÀÌ¿ëÇÏ¿© °¢ À¯ÇüÀ» ºñ±³ °üÂû
ÇÏ¿´´Ù. Quick(Q)ÇüÀº ¿ìÀ¯ À¯¹ß½ÃÇè ÈÄ 1½Ã°£ À̳»¿¡ µÎµå·¯±âÇü ¹ßÁø µîÀÌ ¹ßÇöÇÑ °æ¿ì
·Î, Slow(S)ÇüÀº À¯ÇعÝÀÀÀÌ 1½Ã°£¿¡¼­ 24½Ã°£ »çÀÌ¿¡ ¹ßÇöÇÑ °æ¿ì·Î, Quick & Slow
(Q&S)ÇüÀº QÇü°ú SÇüÀÇ Áõ»óÀÌ ÇÔ²² ³ªÅ¸³ª´Â °æ¿ì·Î ºÐ·ùÇÏ¿´´Ù.

°á°ú : 1) ´ë»óȯ¾Æ 30¸í Áß QÇü 5·Ê, SÇü 20·Ê, Q&SÇü 5·Ê·Î SÇüÀÇ È¯¾Æ°¡ °¡Àå ¸¹¾Ò´Ù.
2) ÀÔ¿ø´ç½Ã ¿¬·ÉÀº QÇü 81.4¡¾67.1ÀÏ, SÇü 31.9¡¾12.7ÀÏ, Q&SÇü 366.0¡¾65.0ÀÏ·Î °¢ À¯Çü¿¡
µû¶ó È£¹ß ¿¬·ÉÀÇ Â÷À̸¦ º¸¿´´Ù(p<0.05). ÀÔ¿ø´ç½Ã üÁßÀº QÇü 10¡­50¹éºÐÀ§¼ö, SÇü 10¹é
ºÐÀ§¼ö ÀÌÇÏ, Q&SÇü 10¡­25¹éºÐÀ§¼ö·Î SÇü°ú ´Ù¸¥ À¯Çü°£¿¡ Â÷À̸¦ º¸¿´À¸¸ç(p<0.05), SÇü
ȯ¾Æ Áß 90%¿¡¼­ 3¹éºÐÀ§¼ö ÀÌÇÏ·Î °üÂûµÇ¾ú´Ù. 3) ÀÔ¿ø´ç½Ã ¸»ÃÊÇ÷¾×°Ë»ç»ó ¹éÇ÷±¸¼ö´Â Q
Çü 5,700¡­12,300/§§, SÇü 10,000¡­33,400/§§, Q&SÇü 5,200¡­14,900/§§·Î SÇü°ú ´Ù¸¥ À¯Çü°£
¿¡ Â÷À̸¦ º¸¿´´Ù(p<0.05>. ÀÔ¿ø´ç½Ã Ç÷Áß ¾ËºÎ¹ÎÄ¡´Â QÇü 4.2¡¾0.4g/dl, SÇü 3.0¡¾0.3g/dl,
Q&SÇü 4.0¡¾0.3g/dl·Î SÇü°ú ´Ù¸¥ À¯Çü°£¿¡ Â÷À̸¦ º¸¿´À¸¸ç(p<0.05), SÇü ȯ¾Æ Áß 85%¿¡
¼­ Ç÷Áß ¾ËºÎ¹ÎÄ¡°¡ 3.5g/dl ÀÌÇÏ¿´´Ù. 4) ¼ÒÀå Á¶Á÷»ý°ËÀÇ ÇüÅÂÇÐÀû ºÐ¼®¿¡¼­ À¶¸ðÀÇ ³ôÀÌ
´Â QÇü, Q&SÇüÀº Á¤»ó ´ëÁ¶±º°ú À¯ÀÇÇÑ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾ÒÀ¸³ª, SÇü¿¡¼­´Â ÀǹÌÀÖ´Â °¨
¼Ò¸¦ º¸¿´À¸¸ç(p<0.05), 45%¿¡¼­ ¾ÆÀü À¶¸ðÀ§Ãà(subtotal villous atrophy), 55%¿¡¼­ ºÎºÐ
(partial) À¶¸ðÀ§ÃàÀÇ ¼Ò°ßÀÌ º¸¿© Àü·Ê¿¡¼­ À庴Áõ(enteropathy) ¼Ò°ßÀÌ °üÂûµÇ¾ú´Ù. 5) ÃßÀû
°üÂû Áß Å¸ À½½Ä¹°¿¡ ´ëÇÑ ¾Ë·¹¸£±âÀÇ ¹ßÇöÀº SÇüÀÇ È¯¾Æ±º¿¡¼­´Â ȯ¾ÆÀÇ ¿¬·É, Àü½Å »óÅÂ
ÀÇ ºÒ¾ÈÁ¤°ú À§Ç輺 µî À±¸®Àû Ãø¸éÀ» °í·ÁÇÏ¿© À¯¹ß½ÃÇèÀ» ½ÃÇàÇÏÁö ¾Ê¾ÒÀ¸¸ç, QÇü¿¡¼­µµ
ȯ¾ÆÀÇ ¿¬·ÉÀ» °í·ÁÇÏ¿© ´Ù¾çÇÑ À¯¹ß½ÃÇèÀº Á¦ÇÑÇÏ¿´À¸³ª, ´ë°³ ¿ìÀ¯, ´ëµÎÀ¯, ÀÌÀ¯½Ä ºÐÀ¯,
°è¶õ µî 1¡­2°¡ÁöÀÇ À½½Ä¹°¿¡ À¯ÇØ ¹ÝÀÀÀ» º¸ÀÌ´Â °ÍÀ¸·Î °üÂûµÇ¾ú´Ù. Q&SÇü ±º¿¡¼­´Â ¿¬
·É¿¡ µû¸¥ ÀÌÀ¯ ½ÄÀÌÀÇ Çʿ伺¿¡ µû¶ó ´Ù¾çÇÑ À¯¹ß½ÃÇèÀ» ½ÃÇàÇÏ¿´À¸¸ç, °è¶õ, °¨ÀÚ, »õ¿ì
µî Çػ깰, µÎºÎ, »ç°ú, ´ç±Ù, ¼è°í±â ´ß°í±â µî ȯÀÚ¿¡ µû¶ó ´Ù¾çÇÑ À½½Ä¹°¿¡ À¯ÇعÝÀÀÀ» º¸
ÀÌ´Â °ÍÀ¸·Î °üÂûµÇ¾ú´Ù. 6) ÀÔ¿ø´ç½Ã Ç÷Áß IgEÄ¡, È£»ê±¸¼ö, ¿ìÀ¯´Ü¹é RASTÄ¡, Äá´Ü¹é
RASTÄ¡, ÇǺιÝÀÀ°Ë»ç´Â À¯Çü°£¿¡ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù.

°á·Ð : À§Àå°ü Áõ¼¼ À§ÁÖ·Î ¹ßÇöÇÏ´Â ¿ìÀ¯ ¾Ë·¹¸£±â´Â À¯¹ß ½ÃÇè¿¡ µû¸¥ À¯ÇØ ¹ÝÀÀÀÇ ¹ßÇö
½Ã±â ¹× ¾ç»ó¿¡ µû¶ó 3°¡Áö À¯ÇüÀ¸·Î ºÐ·ùµÉ ¼ö ÀÖÀ¸¸ç, À̵éÀÇ ÀÓ»ó¼Ò°ß, ¼ÒÀå»ý°ËÁ¶Á÷, ¼Ò
°ß, ¸é¿ªÇÐÀû °Ë»ç ¼Ò°ß, Ÿ À½½Ä¹°¿¡ ´ëÇÑ ¾Ë·¹¸£±â ¹ßÇö À¯¹« µî¿¡¼­ °¢ À¯Çüº°·Î Ư¡Àû
ÀÎ ÀÓ»ó ¾ç»óÀ» °üÂûÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌµé ¼Ò°ßÀ» ºñ±³, ºÐ¼®ÇÏ¿© °¨º° Áø´ÜÇÏ´Â °ÍÀÌ
CMA-GIÀÇ Áø´Ü ¹× Ä¡·áÀû Á¢±Ù¿¡¼­ È¿¿ë¼ºÀÌ ³ôÀ» °ÍÀ¸·Î ÆǴܵȴÙ.

Purpose : During the first year of life, cow¡¯s milk protein is the major offender
causing food allergy. Cow¡¯s milk allergy (CMA) affects 2¡­7% of infants, of which
approximately one-half show predominantly gastrointestinal symptoms. We studied the
clinical types of cow¡¯s milk allergy with predominantly gastrointestinal symptoms
(CMA-GI) of childhood.

Methods : The retrospective study was performed on 30 (male 22, female 8) patients
who had diagnosed as CMA-GI during 2 years and 3 months from March 1995 to June
1997.

Results : 1) Children with CMA-GI presented in the three types of clinical
manifestation on the basis of time to reaction to milk ingestion: Quick (Q) onset (5
cases), Slow (S) onset (20 cases), Quick & Slow (Q&S) (5 cases). 2) Age on admission
of the three groups was significantly different (p<0.05): (Q onset: 81.4¡¾67.1 days, S
onset: 31.9¡¾12.7 days, Q&S: 366.0¡¾65.0 days). Although the body weight at birth was
10¡­95 percentile in all patients, body weight on admission was different: (Q onset: 10¡­
50 percentile, S onset: below 10 percentile, Q&S: 10¡­25 percentile). S onset group was
significantly different compared with other groups (p<0.05) and 90% of this one was
failure to thrive below 3 percentile. 3) Peripheral leukocyte counts were as followings:
(Q onset: 5,700¡­12,300/§§, S onset: 10,000¡­33,400/§§, Q&S 5,200¡­14,900/§§). Slow
onset group was significantly different compared with other groups (p<0.05). Serum
albumin levels on admission were as followings: (Q onset: 4.2¡¾0.4g/dl, S onset: 3.0¡¾
0.3g/dl, Q&S: 4.0¡¾0.3g/dl). S onset froup was significantly different compared with other
groups(p<0.05) and 85% of this one was below 3.5g/dl. 4) Although morphometrical
analysis on small intestinal mucosa did not show enteropathy in Q onset and Q&S
groups, all cases of S onset revealed enteropathy: 45% of this one showed subtotal
villous atrophy, 55% showed partial villous atrophy. 5) Allergic reaction test to other
foods was not performed in S onset group because of ethical problem and high risk in
general condition. In Q onset group, allergic reaction to one or two other foods: soy
formula, weaning formula and eggs. Q&S group revealed allergic reactions to several
foods or to most of all foods except protein hydrolysate formula: eggs, potatos, some
kinds of sea food, apples, carrots, beef and chicken. 6) Serum IgE level, peripheral
eosinophil counts, milk RAST, soy RAST, skin test were not significantly different
among groups.

Conclusion : CMA-GI may present in three clinical ways on the basis of time to
reaction to milk ingestion, typical clinical findings and morphologic changes in the small
bowel mucosal biopsy specimens. This clinical subdivision might be helpful in diagnostic
and therapeutic approaches in CMA-GI. Early suspicion is mandatory especially in S
onset type because of high risks with malnutrition and enteropathy.

Å°¿öµå

Cow¡¯s milk allergy; Intestinal; Clinical manifestation;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS